Abstract
Aberrant activation of phosphatidylinosito-4,5-bisphosphate 3-kinase/protein kinase B (PI3K/AKT) signaling in cancer has led to pursuit of inhibitors for targeting this pathway. However, inhibitors of PI3K and AKT have failed to yield efficacious results without adverse effects. Here, we screened a library containing 441 authenticated traditional chinese medicine (TCM) plant extracts by examining their effect on cell viability of a human mammary epithelial cell line HMEC-PIK3CAH1047R, which expresses mutant PIK3CAH1047R and has constitutively active AKT signaling. We found that Oridonin, an extract from Rabdosia rubescens, reduced cell viability to the greatest extent. Oridonin binds to AKT1 and potentially functions as an ATP-competitive AKT inhibitor. Importantly, Oridonin selectively impaired tumor growth of human breast cancer cells with hyperactivation of PI3K/AKT signaling. Moreover, Oridonin prevented the initiation of mouse mammary tumors driven by PIK3CAH1047R. Our results suggest that Oridonin may serve as a potent and durable therapeutic agent for the treatment of breast cancers with hyperactivation of PI3K/AKT signaling.
References
Oct 1, 1988·Planta medica·T FujitaT Togo
Nov 16, 2002·Nature Structural Biology·Jing YangDavid Barford
Jun 5, 2003·Cancer Cell·Jean J ZhaoWilliam C Hahn
Sep 10, 2003·International Journal of Oncology·Takayuki IkezoeH Phillip Koeffler
Jun 24, 2004·Seminars in Cell & Developmental Biology·Ramon Parsons
Jul 16, 2004·Cancer Biology & Therapy·Kurtis E BachmanBen Ho Park
Dec 21, 2004·Oncogene·Jong Woo LeeSug Hyung Lee
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Douglas A LevineJeff Boyd
May 3, 2005·Nature Reviews. Cancer·Nancy E Hynes, Heidi A Lane
Dec 15, 2005·The Journal of Pathology·Fiamma ButtittaAntonio Marchetti
Feb 3, 2006·Nature Reviews. Cancer·Megan CullyTak W Mak
Jan 2, 2007·Blood·Guang-Biao ZhouZhu Chen
Jul 6, 2007·Nature·John D CarptenJames E Thomas
Aug 5, 2008·Cancer Research·Katherine Stemke-HaleBryan T Hennessy
Sep 17, 2008·Oncogene·T L Yuan, L C Cantley
Jul 4, 2009·Cancer Cell·Krishna M VasudevanLevi A Garraway
Jul 25, 2009·Nature Reviews. Cancer·Jeffrey A Engelman
Nov 27, 2010·Fitoterapia·David M EisenbergJon Clardy
Aug 9, 2011·Nature Medicine·Pixu LiuJean J Zhao
May 10, 2012·Science Signaling·Kui LinBarbara J Brandhuber
Jul 18, 2012·Genes & Development·Tamara UtermarkJean J Zhao
Aug 24, 2012·Cancer Discovery·Ashish JuvekarGerburg M Wulf
Jul 23, 2013·Genes & Development·Qi WangJean J Zhao
Oct 1, 2013·Nature Medicine·Mariella Gruber FilbinRosalind A Segal
Oct 18, 2013·Cell Cycle·Qi WangJean J Zhao
Feb 1, 2014·Nature Reviews. Drug Discovery·David A Fruman, Christian Rommel
Sep 19, 2014·Biochemical Society Transactions·Abbe R Clark, Alex Toker
Mar 16, 2016·Cancer Cell·Shom GoelJean J Zhao
Citations
Jun 5, 2020·Integrative Cancer Therapies·Aaron A Jones, Scott Gehler
Aug 1, 2020·Frontiers in Immunology·Shaima'a Hamarsheh, Robert Zeiser
Nov 14, 2020·Journal of Biomolecular Structure & Dynamics·Rohit Karn, Isaac Arnold Emerson